Bristol Myers Squibb (BMY) Common Equity (2009 - 2026)
Bristol Myers Squibb's Common Equity came in at $23.4 billion for Q3 2026, up 25.8% from $18.6 billion a year earlier and up 4.9% from the prior quarter.
Bristol Myers Squibb (BMY) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Bristol Myers Squibb's Common Equity was $18.51 billion, up 12.9% from FY2024.
- Common Equity carries a five-year compound annual growth rate of -13.3% (FY2020 to FY2025).
- Going back by year, Common Equity was $16.39 billion in FY2024 (-44.4%), $29.49 billion in FY2023 (-5.2%), $31.12 billion in FY2022 (-13.6%) and $36.01 billion in FY2021 (-5.0%).
- The Q3 2026 figure represents the highest quarterly Common Equity since Q4 2023.
- Year-over-year, Common Equity has increased for seven consecutive quarters, with growth averaging 6.6% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in Q2 2026 (growth of 27.6%), and the weakest in Q1 2024 (a decline of 48.1%).
- Business Quant data shows BMY's Common Equity at $22.32 billion (Q2 2026), $20.1 billion (Q1 2026) and $18.51 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Bristol Myers Squibb | 128.63 Bn | 83.82 Bn | 8.92 Bn | 23.40 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 23.40 Bn |
| Jun 30, 2026 | 22.32 Bn |
| Mar 31, 2026 | 20.10 Bn |
| Dec 31, 2025 | 18.51 Bn |
| Sep 30, 2025 | 18.60 Bn |
| Jun 30, 2025 | 17.49 Bn |
| Mar 31, 2025 | 17.45 Bn |
| Dec 31, 2024 | 16.39 Bn |
| Sep 30, 2024 | 17.20 Bn |
| Jun 30, 2024 | 17.07 Bn |
| Mar 31, 2024 | 16.55 Bn |
| Dec 31, 2023 | 29.49 Bn |
| Sep 30, 2023 | 29.06 Bn |
| Jun 30, 2023 | 32.03 Bn |
| Mar 31, 2023 | 31.89 Bn |
| Dec 31, 2022 | 31.12 Bn |
| Sep 30, 2022 | 32.73 Bn |
| Jun 30, 2022 | 32.66 Bn |
| Mar 31, 2022 | 31.65 Bn |
| Dec 31, 2021 | 36.01 Bn |
Bristol Myers Squibb Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();